Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$70,773,572
+$22,955,650 QoQ
Shares Held
59,006
+13.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#456
of 4,605 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$2,064,775
PutShares
2,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $338,415,690 across 14 Drug Manufacturers - General names. LLY ranks #2 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
336,570 | $85,478,682 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
59,006 | $70,773,572 | |
| 3 | ABBV |
AbbVie Inc.
|
190,827 | $48,019,706 | |
| 4 | MRK |
Merck & Co., Inc.
|
271,475 | $34,884,537 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
417,663 | $24,065,742 | |
| 6 | AMGN |
Amgen Inc
|
47,883 | $17,339,391 | |
| 7 | NVS |
Novartis AG
|
104,792 | $16,423,002 | |
| 8 | PFE |
Pfizer Inc
|
634,638 | $15,282,083 |
All Filings in LLY
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,773,572 | 59,006 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $47,817,922 | 51,989 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $65,165,377 | 60,637 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,064,775 | 2,500 | Put | Sole | 2025-05-13 | |
| 2025-03-31 | $55,900,066 | 67,683 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,246,000 | 5,500 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $60,980,280 | 78,990 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $117,948,735 | 133,134 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $2,214,850 | 2,500 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $2,263,450 | 2,500 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $118,516,957 | 130,903 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,944,900 | 2,500 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $78,464,266 | 100,859 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,457,300 | 2,500 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $53,842,571 | 92,367 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $46,336,056 | 86,266 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $361,810,768 | 673,600 | Put | Defined | 2023-11-14 | |
| 2023-06-30 | $164,143,000 | 350,000 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $121,934,800 | 260,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $40,583,653 | 86,536 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,030,689 | 35,032 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $47,777,240 | 130,596 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $42,231,450 | 130,606 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $40,388,034 | 124,566 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $36,392,758 | 127,083 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $36,822,059 | 133,307 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $29,106,523 | 125,975 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $30,656,297 | 133,567 | Shares | Other | 2021-08-10 | |
| 2021-03-31 | $23,586,398 | 126,252 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $20,674,964 | 122,453 | Shares | Other | 2021-02-11 | |
| 2020-09-30 | $18,800,316 | 127,012 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $20,814,247 | 126,777 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $15,929,356 | 114,831 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||